CONVERSION OF MYCOPHENOLATE MOFETIL (MMF) TO ENTERIC COATED MYCOPHENOLATE SODIUM (EC-MPS) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS

被引:0
|
作者
Matsuda-Abedini, Mina [1 ]
Kiang, Tony K. L. [2 ]
Ensom, Mary H. H. [2 ]
机构
[1] Univ British Columbia, Div Nephrol, BC Childrens Hosp, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
371
引用
收藏
页码:131 / 131
页数:1
相关论文
共 50 条
  • [1] Interest of conversion from mycophenolate mofetil (MMF) to enteric coated mycophenolate sodium EC-MPS in stable renal transplanted children.
    Meneses, Rejane de Paula
    Kotsifas, Cecilia Hallush
    Olandoski, Karen Previdi
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 367 - 367
  • [2] Enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF), it is better to have the choice
    Budde, K
    Salvadori, M
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) : 1165 - 1166
  • [3] Conversion of Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) Ameliorates GI Symptoms in Liver Transplant Patients.
    de Vera, Michael E.
    Hope, Laurie
    Yelochan, Barbara
    Durant, Stephanie
    Lopez-Solis, Roberto
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 531 - 531
  • [4] QUALITY OF LIFE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN RENAL TRANSPLANT RECIPIENTS WITH GASTROINTESTINAL TRACT COMPLAINTS TO MYCOPHENOLATE MOFETIL (MMF). MYVIDA STUDY
    Andres, I
    Font, B.
    Mora, S.
    Lahoz, R.
    Ortega, F.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A311 - A311
  • [5] Long-term safety and tolerability after conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS, myfortic) in stable maintenance renal transplant recipients
    Chapman, J
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03): : A7 - A7
  • [6] Enteric-Coated Mycophenolate Sodium (EC-MPS) Versus Mycophenolate Mofetil (MMF) in African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry
    Narayanan, M.
    Pankewycz, O.
    El-Ghoroury, M.
    Wiland, A.
    Mccague, K.
    Daller, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 316 - 317
  • [7] Pharmacokinetic and pharmacodynamic comparison of mycophenolate mofetil (MMF) and enteric-coated mycophenolate-sodium (EC-MPS) in maintenance renal transplant patients on tacrolimus.
    Budde, K
    Neumayer, HH
    Grohmann, J
    Waiser, J
    Hambach, P
    Bauer, S
    Mai, I
    Sandau, K
    Fischer, W
    Hepburn, H
    Glander, P
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 191 - 191
  • [8] Enteric-coated mycophenolate sodium (EC-MPS) improves GI symptoms and immunosuppression in patients treated with mycophenolate mofetil (MMF)
    Sabbatini, Massimo
    Mirenghi, Francesco
    Caputo, Carmela
    Capone, Domenico
    Gentile, Antonio
    Polichetti, Giuliano
    Basile, Vincenzo
    Gallo, Riccardo
    Apicella, Luca
    Federico, Stefano
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 395 - 395
  • [9] EXPOSURE TO MYCOPHENOLIC ACID ON MYCOPHENOLATE MOFETIL (MMF) AND ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN KIDNEY PANCREAS TRANSPLANT PATIENTS WITH SEVERE GASTROPARESIS
    Belliere, Julie
    Gandia, Peggy
    Melki, Vincent
    Duffas, Jean Pierre
    Rostaing, Lionel
    Kamar, Nassim
    Esposito, Laure
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 : 50 - 50
  • [10] Outcomes Associated with Dose Manipulations of Enteric-Coated Mycophenolate Sodium (EC-MPS) vs. Mycophenolate Mofetil (MMF) in Renal Transplantation.
    Cooper, Matthew
    Slakey, Douglas
    Deering, Kathleen
    Arcona, Steven
    McCann, Erin
    Rasetto, Flavia
    Florman, Sander
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 201 - 201